Literature DB >> 2143097

Pharmacokinetics of phenobarbital in the cat following multiple oral administration.

S M Cochrane1, J M Parent, W D Black, D G Allen, J H Lumsden.   

Abstract

Phenobarbital was administered orally to seven healthy cats at a dose of 5 mg/kg once a day for 21 days. Serum phenobarbital concentrations were determined using a commercial immunoassay technique. A one-compartment model was used to describe the final elimination curve. The elimination half-life (t1/2 b) after the final day of treatment was 43.3 +/- 2.92 h. The large apparent volume of distribution of 695.0 +/- 43.9 mL/kg suggests that the drug was widely distributed within the body. The t1/2 b following multiple oral administration was significantly shorter than previously reported for a single oral dose of phenobarbital in the cat. Analysis of pharmacokinetic results after days 1 and 21 of treatment suggested that the elimination kinetics of phenobarbital did not change significantly with multiple oral administration. It appears that differences in elimination kinetics can exist between populations of cats. These differences emphasize the need for individual monitoring of cats receiving phenobarbital.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2143097      PMCID: PMC1255661     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  22 in total

1.  Pharmacokinetics of phenobarbital following single and repeated doses.

Authors:  C T Viswanathan; H E Booker; P G Welling
Journal:  J Clin Pharmacol       Date:  1979 May-Jun       Impact factor: 3.126

2.  Metabolic interactions among environmental chemicals and drugs.

Authors:  A H Conney; J J Burns
Journal:  Science       Date:  1972-11-10       Impact factor: 47.728

3.  Absorption kinetics and bioavailability of phenobarbital after oral administration to dogs.

Authors:  F Al-Tahan; H H Frey
Journal:  J Vet Pharmacol Ther       Date:  1985-06       Impact factor: 1.786

4.  Bioavailability of oral and intramuscular phenobarbital.

Authors:  C T Viswanathan; H E Booker; P G Welling
Journal:  J Clin Pharmacol       Date:  1978 Feb-Mar       Impact factor: 3.126

5.  Blood levels of drug at the equilibrium state after multiple dosing.

Authors:  J G Wagner; J I Northam; C D Alway; O S Carpenter
Journal:  Nature       Date:  1965-09-18       Impact factor: 49.962

6.  Intravenous phenobarbital therapy in barbiturate and other hypnosedative withdrawal reactions: a kinetic approach.

Authors:  P R Martin; C M Bhushan; B M Kapur; E A Whiteside; E M Sellers
Journal:  Clin Pharmacol Ther       Date:  1979-08       Impact factor: 6.875

7.  The effect of low-dose phenobarbitone on three indices of hepatic microsomal enzyme induction.

Authors:  D E Price; A Mehta; B K Park; A Hay; M P Feely
Journal:  Br J Clin Pharmacol       Date:  1986-12       Impact factor: 4.335

8.  [Induction of cytochrome P 450 by phenobarbital in cats].

Authors:  R Truhaut; R Ferrando; C Graillot; J C Gak; C Fourlon; R Moraillon
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1978-01-30

9.  Pharmacokinetics of phenobarbital in the cat following intravenous and oral administration.

Authors:  S M Cochrane; W D Black; J M Parent; D G Allen; J H Lumsden
Journal:  Can J Vet Res       Date:  1990-01       Impact factor: 1.310

10.  Kinetics of phenobarbital in normal subjects and epileptic patients.

Authors:  A J Wilensky; P N Friel; R H Levy; C P Comfort; S P Kaluzny
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

View more
  5 in total

1.  Systematic review of antiepileptic drugs' safety and effectiveness in feline epilepsy.

Authors:  Marios Charalambous; Akos Pakozdy; Sofie F M Bhatti; Holger A Volk
Journal:  BMC Vet Res       Date:  2018-03-02       Impact factor: 2.741

2.  Interaction of cyclosporine with phenobarbital in cats: a preliminary study.

Authors:  Yuki Hoshino; Takanori Inden; Riko Otaka; Daisuke Fukui; Hiroshi Satoh; Masaaki Katayama
Journal:  J Vet Med Sci       Date:  2019-10-08       Impact factor: 1.267

3.  Feline orofacial pain syndrome (FOPS): a retrospective study of 113 cases.

Authors:  Clare Rusbridge; Sarah Heath; Danièlle A Gunn-Moore; Susan Penelope Knowler; Norman Johnston; Angus Kennedy McFadyen
Journal:  J Feline Med Surg       Date:  2010-05-06       Impact factor: 2.015

Review 4.  Possible drug-drug interaction in dogs and cats resulted from alteration in drug metabolism: A mini review.

Authors:  Kazuaki Sasaki; Minoru Shimoda
Journal:  J Adv Res       Date:  2015-02-24       Impact factor: 10.479

5.  Serum levetiracetam concentrations after transdermal levetiracetam administration, 3 times daily, to healthy cats.

Authors:  Casey Smith; Heidi L Barnes Heller; Nicole Reif; Matthew Van Hesteren; Jennifer M Reinhart
Journal:  J Vet Intern Med       Date:  2019-01-21       Impact factor: 3.333

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.